Claire Dumont
INSERM U1111, UMR5308, 21 Avenue Tony Garnier
Lyon, 69007, France
Lyon, 69007, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Development of nebulized inhalation delivery for fusion-inhibitory lipopeptides to protect non-human primates against Nipah-Bangladesh infection.
Journal: Antiviral research
Published: December 03, 2024
Multifaceted activation of STING axis upon Nipah and measles virus-induced syncytia formation.
Journal: PLoS pathogens
Published: January 24, 2024
Nebulized fusion inhibitory peptide protects cynomolgus macaques from measles virus infection.
Journal: Research square
Published: June 09, 2022
Nebulized fusion inhibitory peptide protects cynomolgus macaques from measles virus infection.
Journal: Nature communications
Published: May 27, 2022
Activation of cGAS/STING pathway upon paramyxovirus infection.
Journal: iScience
Published: January 22, 2021
Nipah virus W protein harnesses nuclear 14-3-3 to inhibit NF-κB-induced proinflammatory response.
Journal: Communications biology
Published: September 15, 2020
Control of Nipah Virus Infection in Mice by the Host Adaptors Mitochondrial Antiviral Signaling Protein (MAVS) and Myeloid Differentiation Primary Response 88 (MyD88).
Journal: The Journal of infectious diseases
Published: December 20, 2019
High Pathogenicity of Nipah Virus from Pteropus lylei Fruit Bats, Cambodia.
Journal: Emerging infectious diseases
Published: December 20, 2019
Measles Virus Bearing Measles Inclusion Body Encephalitis-Derived Fusion Protein Is Pathogenic after Infection via the Respiratory Route.
Journal: Journal of virology
Published: October 29, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026